Philippe Wolgen
Chief Executive Officer presso CLINUVEL PHARMACEUTICALS LIMITED
Patrimonio netto: 32 M $ in data 31/03/2024
Profilo
Philippe Jacques Wolgen is currently the Chief Executive Officer, MD & Director at Clinuvel Pharmaceuticals Ltd.
and also serves as a Director at Clinuvel (UK) Ltd.
He holds an MBA from The Trustees of Columbia University in The City of New York and London Business School, and a doctorate from the University of Utrecht.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 24/11/2023 | 3 425 222 ( 6.83% ) | 32 M $ | 31/03/2024 |
Posizioni attive di Philippe Wolgen
| Società | Posizione | Inizio |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Chief Executive Officer | 01/11/2005 |
Clinuvel (UK) Ltd.
 Clinuvel (UK) Ltd. BiotechnologyHealth Technology Part of Clinuvel Pharmaceuticals Ltd., Clinuvel (UK) Ltd. is a British company founded in 2005 that provides research and development in the field of biotechnology. The private company is based in London, UK. | Director/Board Member | 25/11/2005 |
Formazione di Philippe Wolgen
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| University of Utrecht | Doctorate Degree |
| London Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
| Clinuvel Pharmaceuticals Ltd. | |
Clinuvel (UK) Ltd.
Clinuvel (UK) Ltd. BiotechnologyHealth Technology Part of Clinuvel Pharmaceuticals Ltd., Clinuvel (UK) Ltd. is a British company founded in 2005 that provides research and development in the field of biotechnology. The private company is based in London, UK. | Health Technology |
- Borsa valori
- Insiders
- Philippe Wolgen
